MedPath

Tygacil

Brand Name: Tygacil

Generic Name: Tigecycline

Active
Registration Number

DR-XY31516

Dosage Form

Lyophilized Powder for Injection (IV Infusion)

Issuance Date

January 31, 2022

Expiry Date

January 27, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength50mg
Packaging5 mL Type I clear glass vial (Box of 1's)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Antibacterial
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

TigecyclineActive
Monograph: Tigecycline

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform